147 related articles for article (PubMed ID: 24148119)
1. [Anti-viral treatment: pro or cons type I IFN?].
Whitehead P; Drouet B; Zagury D; Bensussan A
Med Sci (Paris); 2013 Oct; 29(10):836-9. PubMed ID: 24148119
[No Abstract] [Full Text] [Related]
2. [The first answer to viral infections: type I interferon].
Pichlmair A; Pollak M; Bergthaler A
Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051
[TBL] [Abstract][Full Text] [Related]
3. Targeting of type I interferon in systemic autoimmune diseases.
Crow MK; Olferiev M; Kirou KA
Transl Res; 2015 Feb; 165(2):296-305. PubMed ID: 25468480
[TBL] [Abstract][Full Text] [Related]
4. Overview of the biology of type I interferons.
Kalliolias GD; Ivashkiv LB
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S1. PubMed ID: 20392288
[TBL] [Abstract][Full Text] [Related]
5. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
Gutkowski K; Gutkowska D; Bilkiewicz T
Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
[TBL] [Abstract][Full Text] [Related]
6. Type I interferon and autoimmune disease.
Crow MK
Autoimmunity; 2003 Dec; 36(8):445-6. PubMed ID: 14984020
[No Abstract] [Full Text] [Related]
7. The type I interferon system in the development of lupus.
Rönnblom L; Alm GV; Eloranta ML
Semin Immunol; 2011 Apr; 23(2):113-21. PubMed ID: 21292501
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.
Santana-de Anda K; Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
Autoimmun Rev; 2011 Dec; 11(2):98-103. PubMed ID: 21872684
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
10. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.
Sugrue JA; Bourke NM; O'Farrelly C
Front Immunol; 2021; 12():757249. PubMed ID: 34917078
[TBL] [Abstract][Full Text] [Related]
11. Shared and Distinct Functions of Type I and Type III Interferons.
Lazear HM; Schoggins JW; Diamond MS
Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
[TBL] [Abstract][Full Text] [Related]
12. Type I Interferon in Chronic Virus Infection and Cancer.
Snell LM; McGaha TL; Brooks DG
Trends Immunol; 2017 Aug; 38(8):542-557. PubMed ID: 28579323
[TBL] [Abstract][Full Text] [Related]
13. Interferon-omega: Current status in clinical applications.
Li SF; Zhao FR; Shao JJ; Xie YL; Chang HY; Zhang YG
Int Immunopharmacol; 2017 Nov; 52():253-260. PubMed ID: 28957693
[TBL] [Abstract][Full Text] [Related]
14. [Pathological consequences of excess of interferon in vivo].
Lebon P; Crow YJ; Casanova JL; Gresser I
Med Sci (Paris); 2019 Mar; 35(3):232-235. PubMed ID: 30931907
[TBL] [Abstract][Full Text] [Related]
15. [Interferon response: with great power comes great responsibility].
Maarifi G; Smith N; Nisole S
Med Sci (Paris); 2020 Mar; 36(3):206-209. PubMed ID: 32228834
[No Abstract] [Full Text] [Related]
16. The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics.
Taft J; Bogunovic D
J Immunol; 2018 Dec; 201(12):3479-3485. PubMed ID: 30530500
[TBL] [Abstract][Full Text] [Related]
17. Type I interferons in systemic autoimmunity.
Sozzani S; Bosisio D; Scarsi M; Tincani A
Autoimmunity; 2010 Apr; 43(3):196-203. PubMed ID: 20298124
[TBL] [Abstract][Full Text] [Related]
18. Interferons and immune reactivity.
Hooks JJ; Detrick-Hooks B; Levinson AI
J Am Vet Med Assoc; 1982 Nov; 181(10):1111-4. PubMed ID: 6184354
[No Abstract] [Full Text] [Related]
19. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
Mizuguchi J; Takeuchi M; Usui M
Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
[TBL] [Abstract][Full Text] [Related]
20. [T cell immunity in autoimmune disease].
Fujio K
Nihon Rinsho; 2005 Apr; 63 Suppl 4():56-60. PubMed ID: 15861635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
